162 related articles for article (PubMed ID: 3922294)
1. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model.
Blaser J; Stone BB; Zinner SH
Antimicrob Agents Chemother; 1985 Mar; 27(3):343-9. PubMed ID: 3922294
[TBL] [Abstract][Full Text] [Related]
2. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.
Blaser J; Stone BB; Groner MC; Zinner SH
Antimicrob Agents Chemother; 1987 Jul; 31(7):1054-60. PubMed ID: 3116917
[TBL] [Abstract][Full Text] [Related]
3. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model.
Blaser J; Stone BB; Groner MC; Zinner SH
Antimicrob Agents Chemother; 1985 Jul; 28(1):64-8. PubMed ID: 3929682
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
Blaser J
J Antimicrob Chemother; 1991 May; 27 Suppl C():21-8. PubMed ID: 1906863
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
Daschner FD; Steffens A; Langmaack H
Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
7. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Juhlin I; Tunevall G
Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of netilmicin, gentamicin, and amikacin.
Kantor RJ; Norden CW
Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
[TBL] [Abstract][Full Text] [Related]
9. In vitro study of netilmicin compared with other aminoglycosides.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1976 Sep; 10(3):526-34. PubMed ID: 10829
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies of the synergism of piperacillin and netilmicin against blood culture isolates.
Arpi M; Jørgensen PE; Pedersen HF
Chemotherapy; 1986; 32(1):68-74. PubMed ID: 3081304
[TBL] [Abstract][Full Text] [Related]
12. Bacterial resistance after in vitro exposure to amikacin and netilmicin.
van de Klundert JA; Vliegenthart JS; Mouton RP
Eur J Clin Microbiol; 1986 Aug; 5(4):456-8. PubMed ID: 3093226
[No Abstract] [Full Text] [Related]
13. Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.
Barry AL; Miller GH; Hare RS; Jones RN; Thornsberry C
J Clin Microbiol; 1984 Mar; 19(3):311-4. PubMed ID: 6425354
[TBL] [Abstract][Full Text] [Related]
14. Netilmicin: in vitro activity, time-kill evaluation and postantibiotic effect on microorganisms isolated from ocular infections.
Bonfiglio G; Scuderi AC; Russo G
Chemotherapy; 2001; 47(2):117-22. PubMed ID: 11173813
[TBL] [Abstract][Full Text] [Related]
15. Preclinical comparative evaluation of aminoglycosides.
Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones.
Schlaeffer F; Blaser J; Laxon J; Zinner S
J Antimicrob Chemother; 1990 Jun; 25(6):941-8. PubMed ID: 2115038
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic properties of netilmicin in newborn infants.
Siegel JD; McCracken GH; Thomas ML; Threlkeld N
Antimicrob Agents Chemother; 1979 Feb; 15(2):246-53. PubMed ID: 426516
[TBL] [Abstract][Full Text] [Related]
18. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.
Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
Antimicrob Agents Chemother; 1996 Jan; 40(1):35-9. PubMed ID: 8787875
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and clinical studies on T-1982 (cefbuperazone) in the field of pediatrics].
Toyonaga Y; Kurosu Y; Koda N; Ida H; Mochizuki H; Kumagai K; Akatsuka J; Sugita M; Kawamura G; Okabe T; Hori M; Takahashi T
Jpn J Antibiot; 1983 Apr; 36(4):739-70. PubMed ID: 6410101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
